As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Narcolepsy Drugs Market: By Diseases Type: Daytime Extreme Sleepiness, Cataplexia, Others; By Therapeutic Type: Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments

Global Narcolepsy Drugs Market Outlook

The global narcolepsy drugs market reached a value of nearly USD 2.7 billion in 2020 and is further projected to achieve USD 5.9 billion by 2026, recording a CAGR of 10.4% over the forecast period of 2021-2026.

 

Global Narcolepsy Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry is being driven by the rapidly advancing technology, increased investment in the R&D sector by leading pharmaceutical companies, and the rising awareness regarding narcolepsy and its treatment among people.

 

Properties and Applications

Narcolepsy refers to a sleep disorder that causes excessive daytime drowsiness and is characterised by sleep paralysis and hallucinations, among other factors. It is a neurological disorder involving a reduced capacity to control sleep and wake cycles. The global narcolepsy drugs market can be segmented into disease type and therapeutic type.

 

Global Narcolepsy Drugs Market By Diseases Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry can be divided based on its disease types into daytime extreme sleepiness and cataplexia, among others. The industry is broadly categorised based on its therapeutic types into:

  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Sodium Oxybate
  • Selective Serotonin Reuptake Inhibitor
  • Others

The EMR report looks into the regional narcolepsy drugs markets like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

 

Global Narcolepsy Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The increased prevalence of narcolepsy, awareness regarding sleep disorders due to narcolepsy awareness programmes and camps, and the growing presence of reimbursement policies are the major factors that are accelerating the growth of the global narcolepsy drugs market. Further, the rising disposable incomes and increased expenditure in the health care sector by the governments, particularly in the developing nations, is expected to aid the global narcolepsy drugs market over the forecast period. The adverse effects related to narcolepsy drugs, along with the chances of delayed diagnosis or misdiagnosis, are the major drawbacks, which may affect the industry growth in the forecast period.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global narcolepsy drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Arena Pharmaceutical, Inc.
  • Jazz Pharmaceutical Plc
  • Bioprojet Pharma Sarl
  • Ligand Pharmaceuticals Incorporated
  • Shinogi Inc.
  • Takeda Pharmaceutical Company
  • Teva Pharmaceutical Industries Ltd.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Diseases Type, Therapeutic Type, Region
Breakup by Diseases Type Daytime Extreme Sleepiness, Cataplexia, Others
Breakup by Therapeutic Type Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Arena Pharmaceutical, Inc., Jazz Pharmaceutical Plc, Bioprojet Pharma Sarl, Ligand Pharmaceuticals Incorporated, Shinogi Inc., Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

Key Questions Answered in the Report

  • How has the global narcolepsy drugs market performed in the previous years (2016-2020)?
  • What is the forecast assessment of the market for 2021-2026?
  • What are the major drivers for the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major constraints for the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major demand indicators of the global narcolepsy drugs market?
  • What is the degree of competition in the global narcolepsy drugs market?
  • What are the major events and developments taking place within the industry globally?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key findings of the Study
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Inference Data
3    Executive Summary
    3.1    Market Overview
    3.2    Market Analysis 
4    Global Narcolepsy Drugs Market 
    4.1    Global Narcolepsy Drugs Market (2016-2020) & Forecast (2021-2026)
    4.2    Global Narcolepsy Drugs Market Breakup by Diseases Type
        4.2.1    Daytime Extreme Sleepiness
        4.2.2    Cataplexia
        4.2.3    Others
    4.3    Global Narcolepsy Drugs Market Breakup by Diseases Type: Historical Market (2016-2020) & Forecast (2021-2026)
        4.3.1    Daytime Extreme Sleepiness
        4.3.2    Cataplexia
        4.3.3    Others
    4.4    Global Narcolepsy Drugs Market Breakup by Therapeutic Type
        4.4.1    Central Nervous System Stimulants
        4.4.2    Tricyclic Antidepressants
        4.4.3    Sodium Oxybate
        4.4.4    Selective Serotonin Reuptake Inhibitor
        4.4.5    Others
    4.5    Global Narcolepsy Drugs Market Breakup by Therapeutic Type: Historical Market (2016-2020) & Forecast (2021-2026)
        4.5.1    Central Nervous System Stimulants
        4.5.2    Tricyclic Antidepressants
        4.5.3    Sodium Oxybate
        4.5.4    Selective Serotonin Reuptake Inhibitor
        4.5.5    Others
    4.6    Global Narcolepsy Drugs Market Breakup by Region
        4.6.1    North America
            4.6.1.1    United States of America
            4.6.1.2    Canada
        4.6.2    Europe
            4.6.2.1    Germany
            4.6.2.2    United Kingdom
            4.6.2.3    France
            4.6.2.4    Italy
            4.6.2.5    Others
        4.6.3    Asia Pacific
            4.6.3.1    China
            4.6.3.2    Japan
            4.6.3.3    India
            4.6.3.4    ASEAN
            4.6.3.5    Others
        4.6.4    Latin America
            4.6.4.1    Brazil
            4.6.4.2    Argentina
            4.6.4.3    Mexico
            4.6.4.4    Others
        4.6.5    Middle East & Africa
            4.6.5.1    Saudi Arabia
            4.6.5.2    United Arab Emirates
            4.6.5.3    Nigeria
            4.6.5.4    South Africa
            4.6.5.5    Others
    4.7     Global Narcolepsy Drugs Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        4.7.1    North America
            4.7.1.1    United States of America
            4.7.1.2    Canada
        4.7.2    Europe
            4.7.2.1    Germany
            4.7.2.2    United Kingdom
            4.7.2.3    France
            4.7.2.4    Italy
            4.7.2.5    Others
        4.7.3    Asia Pacific
            4.7.3.1    China
            4.7.3.2    Japan
            4.7.3.3    India
            4.7.3.4    ASEAN
            4.7.3.5    Others
        4.7.4    Latin America
            4.7.4.1    Brazil
            4.7.4.2    Argentina
            4.7.4.3    Mexico
            4.7.4.4    Others
        4.7.5    Middle East & Africa
            4.7.5.1    Saudi Arabia
            4.7.5.2    United Arab Emirates
            4.7.5.3    Nigeria
            4.7.5.4    South Africa
            4.7.5.5    Others
5    SWOT Analysis
    5.1    Overview
    5.2    Strengths
    5.3    Weaknesses
    5.4    Opportunities
    5.5    Threats
6    Porter’s Five Forces Analysis
    6.1    Overview
    6.2    Buyer’s Power
    6.3    Supplier’s Power
    6.4    New Entrants
    6.5    Degree of Rivalry
    6.6    Substitutes
7    Key Players & Company Profile Analysis 
    7.1    Arena Pharmaceutical, Inc.
    7.2    Jazz Pharmaceutical Plc
    7.3    Bioprojet Pharma Sarl
    7.4    Ligand Pharmaceuticals Incorporated
    7.5    Shinogi Inc.
    7.6    Takeda Pharmaceutical Company
    7.7    Teva Pharmaceutical Industries Ltd.
    7.8    Others
8    Industry Events and Developments

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER